Standard BioTools Inc.
LAB
$0.90
-$0.06-6.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 21.70% | -10.16% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 21.70% | -10.16% | |||
| Cost of Revenue | 23.29% | -40.34% | |||
| Gross Profit | 20.01% | 94.07% | |||
| SG&A Expenses | -4.73% | -5.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.28% | -5.37% | |||
| Operating Income | 6.58% | 0.98% | |||
| Income Before Tax | 33.04% | -79.96% | |||
| Income Tax Expenses | -2,854.93% | -99.67% | |||
| Earnings from Continuing Operations | 143.87% | -79.28% | |||
| Earnings from Discontinued Operations | 279.22% | 80.98% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 155.59% | -3.67% | |||
| EBIT | 6.58% | 0.98% | |||
| EBITDA | 23.92% | -10.99% | |||
| EPS Basic | 155.24% | -3.19% | |||
| Normalized Basic EPS | 35.25% | -43.45% | |||
| EPS Diluted | 155.24% | -3.19% | |||
| Normalized Diluted EPS | 35.25% | -43.45% | |||
| Average Basic Shares Outstanding | 0.63% | 0.56% | |||
| Average Diluted Shares Outstanding | 0.63% | 0.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||